About
About The Short Peptide
Peptide science, explained so it’s easy to follow. Every guide opens with a plain-language short version, with the full detail right below. Latest Research breaks new studies into what was done, what was found, and what it means. The glossary covers the words you’ll meet along the way. New here? Start with what a peptide is(coming soon).
Who’s behind this site
The Short Peptide is published by Applied Longevity Insights, LLC, and is the educational arm of Pure Fire Nutritional, which funds this site and sells peptide bioregulator supplements. It is run by Julia Shulman, a co-founder of Pure Fire.
Our goal is to make peptide science easier for anyone to find and understand, not just to explain one company’s products. Julia sells what she stands behind on Pure Fire, and she finds the gene-regulation idea behind bioregulators compelling. Our coverage leans toward that research, and we’d rather say so than pretend otherwise. To keep that lean honest, we label every claim by the kind of evidence behind it and say plainly where the research is thin, including for compounds Pure Fire sells.
Article pages don’t sell products, recommend products, or tell you where to buy. Nothing on this site is medical advice. Editorial standards & disclosures
Want to see how we judge a study? → How to read peptide research(coming soon) · Our editorial standards(coming soon)
- One preparation per claim. Extract findings stay with extracts; synthetic findings stay with synthetics.
- Missing facts are marked [source needed]. We do not fill gaps with plausible numbers.
- Unfinished pages say “chapter in progress” instead of padding.
- There's no shop on this site. Our articles teach the science; they don't sell, rank, or recommend products.
The Short Peptide is a publication and a school. We publish study summaries, keep an organ map, and run one course.
The science we cover comes out of a Russian research programme led by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. We are not that institute, we do not speak for it, and we had no relationship with Khavinson, who died in January 2024. Phil Micans and IAS hold the long personal connection to that work. We do not claim it.
We also do not borrow the programme’s numbers. Figures you see quoted about patient counts, study counts, and patents belong to that research programme, not to us, and we cite papers rather than repeat totals.
A small editorial group of translators and educators. Named contributors and their backgrounds: [source needed]. We would rather leave this blank than invent faculty.